Chemoinformaics analysis of 6-METHYL-3,5-HEPTADIEN-2-ONE
| Molecular Weight | 124.183 | nRot | 2 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 3 |
| Exact Molecular Weight | 124.089 | nRing | 0 |
| Solubility: LogS | -1.72 | nHRing | 0 |
| Solubility: LogP | 1.866 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 22.1635 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.407 |
| Synth | 2.804 |
| Natural Product Likeliness | 2.228 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.009 |
| HIA | 0.004 |
| CACO-2 | -4.33 |
| MDCK | 0.0000304 |
| BBB | 0.898 |
| PPB | 0.705656 |
| VDSS | 1.629 |
| FU | 0.35774 |
| CYP1A2-inh | 0.399 |
| CYP1A2-sub | 0.516 |
| CYP2c19-inh | 0.06 |
| CYP2c19-sub | 0.894 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.354 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.793 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.468 |
| CL | 4.816 |
| T12 | 0.833 |
| hERG | 0.016 |
| Ames | 0.433 |
| ROA | 0.697 |
| SkinSen | 0.957 |
| Carcinogencity | 0.628 |
| EI | 0.99 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.956486 |